Home › Stocks › DAWN › All Fund Holders
DAWN — DAY ONE BIOPHARMACEUTICALS I · All Fund Holders
Funds holding (latest): 46 · Reported value held: $797.81M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q1 2026 | 7.04M | $151.03M | 0.00% | Reduce |
| Fidelity International (FIL) history | Q1 2026 | 4.13M | $88.59M | 0.07% | New |
| Vanguard Group history | Q4 2025 | 6.28M | $58.55M | 0.00% | Add |
| Balyasny Asset Management history | Q1 2026 | 2.63M | $56.29M | 0.08% | Add |
| UBS Group AG history | Q1 2026 | 2.31M | $49.42M | 0.01% | Add |
| Geode Capital Management history | Q1 2026 | 1.95M | $41.92M | 0.00% | Add |
| Millennium Management history | Q1 2026 | 1.93M | $41.33M | 0.02% | Add |
| Bank of America Corp history | Q1 2026 | 1.90M | $40.80M | 0.00% | Add |
| Viking Global Investors history | Q3 2024 | 2.56M | $35.64M | 0.13% | Hold |
| Soros Fund Management history | Q1 2026 | 1.54M | $33.00M | 0.39% | New |
| Maverick Capital history | Q3 2024 | 2.11M | $29.45M | 0.58% | Add |
| Renaissance Technologies history | Q1 2026 | 1.30M | $27.81M | 0.04% | Reduce |
| Goldman Sachs Group history | Q1 2026 | 979.24K | $20.99M | 0.00% | Reduce |
| Morgan Stanley history | Q1 2026 | 687.11K | $14.73M | 0.00% | Reduce |
| Northern Trust Corp history | Q1 2026 | 666.18K | $14.28M | 0.00% | Add |
| Charles Schwab Investment Management history | Q1 2026 | 617.56K | $13.24M | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 546.43K | $11.71M | 0.01% | Add |
| AQR Capital Management history | Q1 2026 | 444.47K | $9.53M | 0.00% | Add |
| Wellington Management Group history | Q4 2024 | 731.30K | $9.27M | 0.00% | Add |
| Citadel Advisors history | Q1 2026 | 418.70K | $8.98M | 0.00% | Reduce |
| Marshall Wace history | Q1 2026 | 328.64K | $7.05M | 0.01% | New |
| Citigroup Inc history | Q1 2026 | 243.85K | $5.23M | 0.00% | Add |
| PSP Investments history | Q1 2026 | 236.00K | $5.06M | 0.02% | New |
| BNY Mellon history | Q1 2026 | 231.04K | $4.95M | 0.00% | Add |
| Invesco Ltd history | Q1 2026 | 159.90K | $3.43M | 0.00% | Add |
| MFS Investment Management history | Q1 2026 | 147.01K | $3.15M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q4 2025 | 169.00K | $1.58M | 0.00% | Hold |
| Deutsche Bank AG history | Q1 2026 | 66.44K | $1.42M | 0.00% | Add |
| Wells Fargo & Co history | Q1 2026 | 56.43K | $1.21M | 0.00% | Reduce |
| Franklin Resources history | Q1 2026 | 52.62K | $1.13M | 0.00% | Hold |
| Legal & General Investment Management America history | Q1 2026 | 51.76K | $1.11M | 0.00% | Reduce |
| Two Sigma Investments history | Q1 2026 | 41.50K | $889.76K | 0.00% | New |
| Manulife Financial history | Q1 2026 | 36.19K | $775.83K | 0.00% | Add |
| Point72 Asset Management history | Q1 2026 | 31.94K | $684.75K | 0.00% | Reduce |
| CPP Investments history | Q1 2026 | 28.10K | $602.46K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q1 2026 | 23.64K | $506.83K | 0.00% | Reduce |
| Davidson Kempner Capital Management history | Q2 2023 | 40.00K | $477.20K | 0.01% | New |
| D. E. Shaw & Co history | Q1 2026 | 21.63K | $463.66K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q4 2025 | 43.53K | $405.70K | 0.00% | Reduce |
| Arrowstreet Capital history | Q1 2026 | 15.29K | $327.90K | 0.00% | Reduce |
| Principal Global Investors history | Q1 2024 | 17.98K | $296.98K | 0.00% | Add |
| Prudential Financial history | Q1 2026 | 12.26K | $262.85K | 0.00% | New |
| Lazard Asset Management history | Q1 2026 | 9.36K | $200.76K | 0.00% | Reduce |
| Amundi US history | Q3 2024 | 2.98K | $40.74K | 0.00% | Hold |
| T. Rowe Price Associates history | Q1 2026 | 119.29K | $2.56K | 0.00% | Add |
| PNC Financial Services history | Q1 2026 | 41 | $879 | 0.00% | Add |